ES555602A0 - Procedimiento para la obtencion de 3-amino-1-hidroxi-propan-1,1-difosfonato disordico - Google Patents

Procedimiento para la obtencion de 3-amino-1-hidroxi-propan-1,1-difosfonato disordico

Info

Publication number
ES555602A0
ES555602A0 ES555602A ES555602A ES555602A0 ES 555602 A0 ES555602 A0 ES 555602A0 ES 555602 A ES555602 A ES 555602A ES 555602 A ES555602 A ES 555602A ES 555602 A0 ES555602 A0 ES 555602A0
Authority
ES
Spain
Prior art keywords
disordic
diphosphonate
propan
hydroxy
amino
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES555602A
Other languages
English (en)
Other versions
ES8706707A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Henkel AG and Co KGaA
Original Assignee
Ciba Geigy AG
Henkel AG and Co KGaA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=4263070&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES555602(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ciba Geigy AG, Henkel AG and Co KGaA filed Critical Ciba Geigy AG
Publication of ES555602A0 publication Critical patent/ES555602A0/es
Publication of ES8706707A1 publication Critical patent/ES8706707A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/06—Phosphorus compounds without P—C bonds
    • C07F9/16—Esters of thiophosphoric acids or thiophosphorous acids
    • C07F9/165—Esters of thiophosphoric acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/3804—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)] not used, see subgroups
    • C07F9/3839—Polyphosphonic acids
    • C07F9/3873—Polyphosphonic acids containing nitrogen substituent, e.g. N.....H or N-hydrocarbon group which can be substituted by halogen or nitro(so), N.....O, N.....S, N.....C(=X)- (X =O, S), N.....N, N...C(=X)...N (X =O, S)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Rheumatology (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ES555602A 1984-08-06 1986-06-02 Procedimiento para la obtencion de 3-amino-1-hidroxi-propan-1,1-difosfonato disordico Expired ES8706707A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH376884 1984-08-06

Publications (2)

Publication Number Publication Date
ES555602A0 true ES555602A0 (es) 1987-07-01
ES8706707A1 ES8706707A1 (es) 1987-07-01

Family

ID=4263070

Family Applications (2)

Application Number Title Priority Date Filing Date
ES545899A Expired ES8701188A1 (es) 1984-08-06 1985-08-05 Procedimiento para la obtencion de 3-amino-1-hidroxi-propan-1,1-difosfonato disodico
ES555602A Expired ES8706707A1 (es) 1984-08-06 1986-06-02 Procedimiento para la obtencion de 3-amino-1-hidroxi-propan-1,1-difosfonato disordico

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES545899A Expired ES8701188A1 (es) 1984-08-06 1985-08-05 Procedimiento para la obtencion de 3-amino-1-hidroxi-propan-1,1-difosfonato disodico

Country Status (26)

Country Link
US (2) US4639338A (es)
EP (1) EP0177443B1 (es)
JP (1) JPS6143196A (es)
KR (1) KR940000817B1 (es)
AR (4) AR240832A1 (es)
AT (1) ATE47396T1 (es)
AU (1) AU591066B2 (es)
CA (1) CA1255694A (es)
CY (1) CY1570A (es)
DD (1) DD239597A5 (es)
DE (1) DE3573783D1 (es)
DK (1) DK167282B1 (es)
DO (1) DOP1990004769A (es)
ES (2) ES8701188A1 (es)
FI (1) FI79712C (es)
GR (1) GR851910B (es)
HK (1) HK42591A (es)
HU (1) HU193124B (es)
IE (1) IE58077B1 (es)
IL (1) IL75990A (es)
MX (1) MX9203373A (es)
NO (1) NO165401C (es)
PH (1) PH24854A (es)
PT (1) PT80916B (es)
SG (1) SG91390G (es)
ZA (1) ZA855892B (es)

Families Citing this family (59)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH664158A5 (fr) * 1984-07-18 1988-02-15 Symphar Sa Derives propylidenediphosphonates-1,3 substitues en position 2, leur procede de preparation et compositions pharmaceutiques les contenant.
ES2039237T3 (es) * 1986-04-24 1993-09-16 Fujisawa Pharmaceutical Co., Ltd. Procedimiento para preparar nuevos compuestos de acido difosfonico.
US4963681A (en) * 1987-07-06 1990-10-16 Norwich Eaton Pharmaceuticals, Inc. Process for synthesis of aminomethylene phosphonoalkylphosphinates
IL86951A (en) * 1987-07-06 1996-07-23 Procter & Gamble Pharma Methylene phosphonoalkylphosphinates and pharmaceutical preparations containing them
IT1222734B (it) * 1987-09-25 1990-09-12 Scalvo S P A Formulaziopne farmaceutiche e forme di dosaggio per la somminaistarzione rettale di calcitonina
PH26923A (en) * 1989-03-08 1992-12-03 Ciba Geigy N-substituted amino alkanediphosphonic acids
US4922007A (en) * 1989-06-09 1990-05-01 Merck & Co., Inc. Process for preparing 4-amino-1-hydroxybutylidene-1,1-bisphosphonic acid or salts thereof
PH27186A (en) * 1989-09-07 1993-04-16 Ciba Geigy Ag Double-coated granules of disodium pamidronate
US5019651A (en) * 1990-06-20 1991-05-28 Merck & Co., Inc. Process for preparing 4-amino-1-hydroxybutylidene-1,1-bisphosphonic acid (ABP) or salts thereof
EP0541037A3 (en) * 1991-11-06 1997-02-26 Takeda Chemical Industries Ltd Squalene synthetase inhibitory composition and use thereof
US5270365A (en) * 1991-12-17 1993-12-14 Merck & Co., Inc. Prevention and treatment of periodontal disease with alendronate
TW237386B (es) 1992-04-15 1995-01-01 Ciba Geigy
US5358941A (en) * 1992-12-02 1994-10-25 Merck & Co., Inc. Dry mix formulation for bisphosphonic acids with lactose
US6406714B1 (en) 1992-12-02 2002-06-18 Merck & Co., Inc. Dry mix formulation for bisphosphonic acids
JP3266395B2 (ja) * 1993-11-24 2002-03-18 富士写真フイルム株式会社 有機薬品の晶析方法
TW390813B (en) * 1994-04-29 2000-05-21 Merck & Co Inc Wet granulation formulation for bisphosphonic acids
US20010007863A1 (en) * 1998-06-18 2001-07-12 Merck & Co., Inc. Wet granulation formulation for bisphosphonic acids
GB9408775D0 (en) * 1994-05-04 1994-06-22 Ciba Geigy Ag Use of certain methanebisphosphonic acid derivatives to prevent prothesis loosening and prothesis migration
DE19719680A1 (de) 1997-05-09 1998-11-19 Boehringer Mannheim Gmbh Verwendung von Diphosphonsäuren zur präventiven Behandlung von Spätfolgen bei Harnblasenerweiterung oder Harnblasenersatz
PT891979E (pt) * 1997-07-15 2005-02-28 Gador Sa Uma forma cristalina do mono-hidrato do sal monossodico do acido n,n-dimetil-3-amino-1-hidroxipropan-1,1-difosfonico e o procedimento para a sua preparacao
EP1702924A3 (en) * 1998-08-27 2007-07-18 Teva Pharmaceutical Industries Ltd Novel hydrate forms of alendronate sodium, processes for manufacture thereof, and pharmaceutical compositions thereof
RO122854B1 (ro) 1998-08-27 2010-03-30 Teva Pharmaceutical Industries Ltd. Alendronat de sodiu hidrat, procedeu de obţinere şi compoziţie farmaceutică
EP0998933A1 (de) 1998-10-09 2000-05-10 Boehringer Mannheim Gmbh Verfahren zur Herstellung von bisphosphonathaltigen pharmazeutischen Zusammensetzungen zur oralen Applikation
EP0998932A1 (de) 1998-10-09 2000-05-10 Boehringer Mannheim Gmbh Feste pharmazeutische Darreichungsform enthaltend Diphosphonsäure oder deren Salze und Verfahren zu ihrer Herstellung
US6160165A (en) 1998-12-10 2000-12-12 Aesgen, Inc. Method for preparation of disodium pamidronate
US6794536B1 (en) 1998-12-10 2004-09-21 Aesqen, Inc. Method for preparation of disodium pamidronate
DE69907258T2 (de) * 1998-12-10 2003-11-06 Aesgen Inc Verfahren zur herstellung von dinatriumpamidronat
US6315566B1 (en) 1999-05-18 2001-11-13 3M Innovative Properties Company Dental materials
US6143919A (en) * 1999-05-18 2000-11-07 3M Innovative Properties Company Polymerizable acidic compounds and methods of preparation
US6963008B2 (en) * 1999-07-19 2005-11-08 Teva Pharmaceutical Industries Ltd. Hydrate forms of alendronate sodium, processes for manufacture thereof, and pharmaceutical compositions thereof
ES2153794B1 (es) * 1999-08-06 2001-10-16 Medichem Sa Procedimiento para la obtencion del acido 4-amino-1-hidroxibutiliden-1,1-bisfosfonico y de su sal monosodica trihidratada.
KR100343232B1 (ko) * 1999-12-10 2002-07-10 김재윤 결정성 파미드론산 이나트륨염 수화물과 그의 제조방법
AU2001293473A1 (en) * 2000-09-18 2002-03-26 Mayne Pharma International Pty Ltd Diphosphonate solutions
WO2002058708A1 (en) * 2001-01-23 2002-08-01 Gador S.A. Composition comprising bisphosphonates for prevention and/or treatment of metabolic diseases of bones, process for preparing such composition and use thereof
RU2003134700A (ru) 2001-05-02 2005-03-20 Сикор Инк. (Us) Динатрий памидронат для инъекций
CA2372450A1 (en) * 2001-05-10 2001-09-19 Pharmaceutical Partners Of Canada Inc. Liquid injectable formulation of disodium pamidronate
ITMI20012751A1 (it) * 2001-12-21 2003-06-21 Lyogen Ltd Sale monosodico dell'acido pamidronico e procedimento per la sua preparazione
NZ534104A (en) * 2001-12-24 2007-03-30 Teva Pharma Dosage form with a core tablet of active ingredient sheathed in a compressed annular body of powder or granular material
US20040052843A1 (en) * 2001-12-24 2004-03-18 Lerner E. Itzhak Controlled release dosage forms
EP2316468A1 (en) 2002-02-22 2011-05-04 Shire LLC Delivery system and methods for protecting and administering dextroamphetamine
US20040138180A1 (en) * 2002-10-03 2004-07-15 Barr Laboratories, Inc. Bisphosphonate composition and process for the preparation thereof
ES2530791T3 (es) * 2002-12-20 2015-03-05 Hoffmann La Roche Formulación de ibandronato de altas dosis
US20050119230A1 (en) * 2003-09-18 2005-06-02 Alexandra Glausch Pharmaceutical products comprising bisphosphonated
AU2003286309A1 (en) * 2003-12-04 2005-06-24 Mustafa Nevzat Ilac Sanayii A.S. Method for producing pure disodium pamidronate
DE602005022578D1 (de) 2004-05-24 2010-09-09 Warner Chilcott Co Llc Enterische feste orale dosierform eines bisphosphonats mit einem chelate
EP1802641B8 (en) * 2004-10-08 2012-03-07 The Board Of Trustees Of The University Of Illinois Bisphosphonate compounds and methods for bone resorption diseases, cancer, bone pain, immune disorders, and infectious diseases
WO2008128056A1 (en) * 2004-10-08 2008-10-23 The Board Of Trustees Of The University Of Illinois Bisphosphonate compounds and methods with enhanced potency for multiple targets including fpps, ggpps, and dpps
US7687482B2 (en) * 2006-03-17 2010-03-30 The Board Of Trustees Of The University Of Illinois Bisphosphonate compounds and methods
EP2136814A4 (en) * 2007-03-21 2012-05-30 Univ Duke MEDICAL KITS AND FORMULATIONS FOR PREVENTING, TREATING OR REDUCING SECONDARY FRACTURES FROM A PREVIOUS FRACTURE
AU2008350907A1 (en) 2007-12-11 2009-08-27 Viamet Pharmaceuticals, Inc. Metalloenzyme inhibitors using metal binding moieties in combination with targeting moieties
CN102639137A (zh) 2009-09-01 2012-08-15 杜克大学 双膦酸类组合物及其治疗心力衰竭的方法
FR2954320B1 (fr) 2009-12-17 2012-06-15 Cll Pharma Composition pharmaceutique orale suprabiodisponible contenant un acide biphosphonique ou un de ses sels
JP2013525294A (ja) 2010-04-16 2013-06-20 ノバルティス アーゲー インプラント骨結合を改善するための方法および組成物
EP2780021A4 (en) 2011-11-16 2015-08-05 Univ Duke BISPHOSPHONATE COMPOSITIONS AND METHODS FOR TREATING AND / OR REDUCING HEART FAILURE
GB201200868D0 (en) 2012-01-19 2012-02-29 Depuy Int Ltd Bone filler composition
US11654152B2 (en) 2012-05-14 2023-05-23 Antecip Bioventures Ii Llc Compositions for oral administration of zoledronic acid or related compounds for treating disease
CN109331027A (zh) * 2012-05-14 2019-02-15 安泰赛普生物风投二代有限责任公司 用于减轻炎性疼痛或相关病症的包含唑来膦酸或相关化合物的组合物
KR101995432B1 (ko) * 2016-10-13 2019-07-02 엘지전자 주식회사 공기조화기 및 그 제어방법
EP3553067A1 (en) * 2018-04-10 2019-10-16 Abiogen Pharma S.p.A. Polymorph of sodium neridronate and preparation process thereof

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2130794C3 (de) * 1971-06-22 1974-07-11 Joh. A. Benckiser Gmbh, 6700 Ludwigshafen Verfahren zur Herstellung von l-Hydroxy-S-amino-propan-ljl-diphosphonsäure
DE2405254C2 (de) * 1974-02-04 1982-05-27 Henkel KGaA, 4000 Düsseldorf Verwendung von 3-Amino-1-Hydroxypropan-1, 1-diphosphonsäure oder ihrer wasserlöslichen Salze bei der Beeinflußung von Calciumstoffwechselstörungen im menschlichen oder tierischen Körper
US4134969A (en) * 1974-02-04 1979-01-16 Henkel Kommanditgesellschaft Auf Aktien (Henkel Kgaa) Method of treatment of calcium disorders using aminoalkane-diphosphonic acids
DE2534391C2 (de) * 1975-08-01 1983-01-13 Henkel KGaA, 4000 Düsseldorf 1-Hydroxy-3-aminoalkan-1,1-diphosphonsäuren
DE2553963A1 (de) * 1975-12-01 1977-06-08 Henkel & Cie Gmbh Pharmazeutische praeparate zur behandlung von stoerungen des calciumstoffwechsels
DK506476A (da) * 1975-12-01 1977-06-02 Henkel & Cie Gmbh Farmaceutiske preparater til behandling af calciumstofs skifteforstyrrelser
JPS5283957A (en) * 1975-12-01 1977-07-13 Henkel & Cie Gmbh Medicine for treating metabolic obstruction of calcium
SE409706B (sv) * 1976-05-21 1979-09-03 Astra Pharma Prod Forfarande for framstellning av n,n-dimetyl-3-(4-bromfenyl)-3-3(3-pyridyl)-allylamin dihydroklorid monohydrat
DE2702631A1 (de) * 1977-01-22 1978-07-27 Henkel Kgaa Verfahren zur herstellung von 1-hydroxy-3-amino-propan-1,1-diphosphonsaeuren
DE2943498C2 (de) * 1979-10-27 1983-01-27 Henkel KGaA, 4000 Düsseldorf Verfahren zur Herstellung von 3-Amino-1-hydroxypropan-1,1-diphosphonsäure
DE3016289A1 (de) * 1980-04-28 1981-10-29 Henkel KGaA, 4000 Düsseldorf Verfahren zur herstellung von omega -amino-1-hydroxyalkyliden-1,1-bis-phosphonsaeuren
US4304734A (en) * 1980-10-16 1981-12-08 Vysoka Skola Chemicko-Technologicka 6-Amino-1-hydroxyhexylidene diphosphonic acid, salts and a process for production thereof
DE3151038A1 (de) * 1981-12-23 1983-07-28 Henkel KGaA, 4000 Düsseldorf Verfahren zur herstellung von 3-amino-1-hydroxypropan-1,1-diphosphonsaeure
US4446052A (en) * 1982-05-17 1984-05-01 The Procter & Gamble Company Aqueous gel containing tricalcium di(1-hydroxy-3-aminopropane-1,1-diphosphonate
CH664158A5 (fr) * 1984-07-18 1988-02-15 Symphar Sa Derives propylidenediphosphonates-1,3 substitues en position 2, leur procede de preparation et compositions pharmaceutiques les contenant.

Also Published As

Publication number Publication date
DK355485A (da) 1986-02-07
AR240832A1 (es) 1991-02-28
HU193124B (en) 1987-08-28
DK355485D0 (da) 1985-08-05
JPH058717B2 (es) 1993-02-02
NO165401C (no) 1991-02-06
PT80916B (pt) 1987-12-30
ES545899A0 (es) 1986-11-16
HK42591A (en) 1991-06-07
AR244697A1 (es) 1993-11-30
AU591066B2 (en) 1989-11-30
ZA855892B (en) 1986-03-26
CY1570A (en) 1991-12-20
FI852986A0 (fi) 1985-08-02
CA1255694A (en) 1989-06-13
AU4577785A (en) 1986-02-13
US4711880A (en) 1987-12-08
ATE47396T1 (de) 1989-11-15
EP0177443B1 (de) 1989-10-18
FI79712C (fi) 1990-02-12
PH24854A (en) 1990-12-26
SG91390G (en) 1991-01-18
DE3573783D1 (en) 1989-11-23
KR940000817B1 (ko) 1994-02-02
DD239597A5 (de) 1986-10-01
DOP1990004769A (es) 1999-08-19
FI852986L (fi) 1986-02-07
NO853087L (no) 1986-02-07
AR240832A2 (es) 1991-02-28
JPS6143196A (ja) 1986-03-01
US4639338A (en) 1987-01-27
HUT38361A (en) 1986-05-28
IE851931L (en) 1986-02-06
KR860001821A (ko) 1986-03-22
AR244696A1 (es) 1993-11-30
EP0177443A1 (de) 1986-04-09
PT80916A (en) 1985-09-01
AR244698A1 (es) 1993-11-30
IL75990A (en) 1989-07-31
MX9203373A (es) 1992-09-01
FI79712B (fi) 1989-10-31
IE58077B1 (en) 1993-06-30
GR851910B (es) 1985-12-03
ES8706707A1 (es) 1987-07-01
DK167282B1 (da) 1993-10-04
ES8701188A1 (es) 1986-11-16
NO165401B (no) 1990-10-29

Similar Documents

Publication Publication Date Title
ES545899A0 (es) Procedimiento para la obtencion de 3-amino-1-hidroxi-propan-1,1-difosfonato disodico
ES540597A0 (es) Procedimiento para la obtencion de piridonas.
ES553083A0 (es) Procedimiento para la obtencion de acidos 7-amino-1-ciclopropil-6,8-dihalogeno-1,4-dihidro-4-oxo-3-quinolincarboxilico
ES539782A0 (es) Procedimiento para la obtencion de 5-amino-1-fenil-pirazolessustituidos
ES555050A0 (es) Procedimiento para la obtencion de aril-ciclopropil-oxiranos
ES557316A0 (es) Procedimiento para la obtencion de derivados de 5-amino-4-hidrovalerilo.
ES552398A0 (es) Procedimiento para la obtencion de poli-hidro piridazo diacepinas, triacepinas o diazocinas
ES539822A0 (es) Procedimiento para la preparacion de pirazolopiridinas.
ES544341A0 (es) Procedimiento para la obtencion de heteroariloxiacetamidas
ES543386A0 (es) Procedimiento para la obtencion de 1-heteroaril-4-aril-pira-zolin-5-onas
ES542207A0 (es) Procedimiento para la obtencion de tetrahidrofuran-2-ilmeti-laminas
ES545967A0 (es) Procedimiento para la obtencion de poliarilensulfuro
ES550219A0 (es) Procedimiento para la obtencion de aminopolieteres alcoxi- lados
ES549255A0 (es) Procedimiento para la obtencion de halogeno-hidroxi-flavonas
ES543820A0 (es) Procedimiento para la obtencion de piperacinil-oxo-quinoli- nas
ES549266A0 (es) Procedimiento para la obtencion de n-halo-carbonil-fenilhi- drazinas substituidas
ES543387A0 (es) Procedimiento para la obtencion de pirazolin-5-onas susti- tuidas
ES544511A0 (es) Procedimiento para la obtencion de fenoxialquilaminopropano-les substituidos
ES540173A0 (es) Procedimiento para la obtencion de nuevos 1,3,2-dioxaborina-nos
ES550351A0 (es) Procedimiento para la produccion de 8-alfa-acilamino-ergolinas.
ES544459A0 (es) Procedimiento para la obtencion de benzo -c- -1,8-naftiridi-nas
ES554606A0 (es) Procedimiento para la obtencion de piridiletil-dihidropiridinas
ES546549A0 (es) Procedimiento para la obtencion de fluoralcoxifenilsulfonil-guanidinas
ES546551A0 (es) Procedimiento para la obtencion de arisulfonilguanidinas sustituidas
ES539626A0 (es) Procedimiento para la preparacion de nuevas 3-alcoxi-2-(n-pirrolidino)-n-pirimidinil-o-n-pirazinil propilaminas.

Legal Events

Date Code Title Description
PC1A Transfer granted
FD1A Patent lapsed

Effective date: 20070508